CALGARY, AB (February 12, 2020) — Zephyr Sleep Technologies (Zephyr) is partnering with ProSomnus® Sleep Technologies (ProSomnus) in a non-exclusive co-marketing arrangement that gives ProSomnus the ability to sell Zephyr’s MATRx plus™ to ProSomnus customers and prospects, and in turn, Zephyr will market ProSomnus sleep and snore devices to Zephyr customers.
“We have been working closely with ProSomnus over a number of years and are pleased that they are becoming a channel to sell MATRx plus directly,” says Paul Cataford, Chief Executive Officer, Zephyr. “ProSomnus provides innovative, comfortable and clinically-validated oral appliances, and we share a common vision – to offer the best care and most efficient workflow for dental clinics to treat their patients suffering from sleep apnea.”
“ProSomnus and Zephyr have a history of successfully collaborating to advance dental sleep medicine for patients who fail or refuse CPAP and to leading Dental Sleep Medicine providers,” stated Len Liptak, CEO. “This agreement facilitates our future market development activities.”
The proprietary MATRx plus is an easy-to-use, FDA cleared tablet that gathers and communicates sleep and airway data securely over the internet. It is used by the patient in their home and the data is communicated to health professionals to:
- Identify whether the patient has sleep apnea
- Determine if the patient will respond to oral appliance therapy
- Identify target protrusive position for effective oral appliance treatment in advance of appliance fabrication
The MATRx plus provides the dental team and their patients the most accurate and efficient means of testing and fitting of an oral appliance in the treatment of obstructive sleep apnea. It offers a simpler, faster and easier path to treatment. Traditional methods of providing oral appliances are often timeconsuming and inconsistent, with a failure rate in the range of 40%. The MATRx plus™ system provides a positive predictive value of 100% when identifying patients who will be successfully treated with an oral appliance.
The MATRx plus is now offered in over 300 dental clinics across the US.
About ProSomnus® Sleep Technologies ProSomnus® Sleep Technologies designs, manufactures and markets FDA Cleared Class II Medical Devices dentists use to treat patients diagnosed with Obstructive Sleep Apnea. ProSomnus® Devices are the first, precision oral appliance therapy devices designed to enhance compliance, mitigate side effects and, enable dentists to achieve excellent patient experiences and outcomes. They have been used to treat thousands of patients, with clinical performance that has been validated in randomize controlled trials, retrospective cohort studies, and numerous clinical case reports.
About Zephyr Sleep Technologies
Zephyr Sleep Technologies helps people live healthier, more productive lives by sleeping better. The company provides medical professionals with a progressive, precise and easy-to-use at-home sleep testing and fitting device that enables a dentist to effectively tailor an oral appliance to treat the patient’s sleep apnea with confidence and precision. Our mission is to empower health professionals to enhance patient care by providing a simple solution to sleeping better – simply, better sleep care. The company is headquartered in Calgary, Alberta and was founded in 2010.
For more information, please contact:
Shauna Peets Manager, Marketing Communications
Zephyr Sleep Technologies